Table 3. The effect of male sex to the prevalence of skin findings and diseases, compared to females.

	Unadjusted RRs		Adjusted* RRs
	RR	95% CI	aRR	95% CI
Benign skin tumor
Dermatofibroma	0.66	0.55–0.78	0.66	0.55–0.79
Cherry angioma	0.81	0.75–0.87	0.81	0.75–0.88
Seborrheic keratosis	0.87	0.78–0.96	0.87	0.78–0.96
Lentigo senilis	0.61	0.48–0.77	0.61	0.48–0.77
Lipoma	2.38	1.40–4.02	2.40	1.42–4.06
Naevus flammeus	0.75	0.64–0.88	0.75	0.64–0.88
Skin infections	1.57	1.41–1.74	1.56	1.40–1.73
Onychomycosis	2.65	1.96–3.60	2.63	1.94–3.56
Tinea pedis	1.99	1.71–2.33	1.98	1.70–2.31
Folliculitis	3.32	2.21–4.98	3.27	2.18–4.91
Sebaceus gland diseases	0.80	0.69–0.93	0.79	0.68–0.92
Acne scars	1.40	1.07–1.84	1.39	1.06–1.83
Rosacea	0.55	0.44–0.69	0.54	0.43–0.68
Erytematoteleangiectatic	0.55	0.43–0.71	0.54	0.42 – 0.70
Papulopustular	0.42	0.22–0.81	0.42	0.22–0.81
Perioraldermatitis	0.09	0.01–0.68	0.09	0.01–0.70
Eczemas	1.28	1.11–1.48	1.28	1.10–1.48
Atopic eczema	0.70	0.46–1.05	0.70	0.47–1.06
Hand eczema	0.73	0.54–0.98	0.73	0.54–0.98
Seborrheic eczema	3.79	2.59–5.54	3.78	2.59–5.53
Eczema nummulare	2.41	1.22–4.77	2.37	1.21–4.67
Eczema infectiosum	3.47	1.48–8.13	3.36	1.43–7.86
Contact eczema	0.14	0.03–0.59	0.13	0.03–0.58
Neurodermatitis	3.34	1.58–7.10	3.36	1.59–7.10
Hair follicle diseases	29.16	19.75–43.04	29.13	19.73–43.02
Androgenetic alopecia	50.74	30.10–85.53	50.73	30.09–85.52
Hyperhidrosis	3.71	1.83–7.50	3.68	1.82–7.47

Abbrevations: RR, relative risk; aRR, adjusted relative risk; CI, confidence interval.

* Adjusted for education.